PD L1 News and Research

RSS
Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

NSCLC patients treated with KRAS G12C inhibitor sotorasib may receive long-term clinical benefit

NSCLC patients treated with KRAS G12C inhibitor sotorasib may receive long-term clinical benefit

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

City of Hope's late-breaking clinical trial data to be presented at AACR

City of Hope's late-breaking clinical trial data to be presented at AACR

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Biological timeline of COVID-19 immune recovery described in new research

Biological timeline of COVID-19 immune recovery described in new research

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Combined strategy suppresses the growth of deadly brain tumor

Combined strategy suppresses the growth of deadly brain tumor

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

Fiber-rich diet may help some melanoma patients to respond to immunotherapy

Fiber-rich diet may help some melanoma patients to respond to immunotherapy

Nanoparticle therapeutic can be a potential new approach for treating malignant pleural effusion

Nanoparticle therapeutic can be a potential new approach for treating malignant pleural effusion

Distinct plasma proteins linked to presence and course of COVID-19

Distinct plasma proteins linked to presence and course of COVID-19

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Deadly parasite could potentially be used to treat various types of cancers

Deadly parasite could potentially be used to treat various types of cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.